By Dale Hunt

Photo Credit: My 420 Tours – Image licensed under the Creative Commons Attribution-Share Alike 4.0 International license.

 

Several years ago, I was sharing drinks and conversation with some friends at a Cannabis industry meeting when the topic of correct terminology arose.  Specifically, this happened when I used the term “strain” in the way it is commonly used in reference to Cannabis.  A friend pointed out that this term was not ideal for professional conversations, especially conversations with scientists and businesspeople.  I was warned that these audiences may see such usage as imprecise, unsophisticated, and reflective of a lack of awareness of more proper terminology such as “variety” or “cultivar.”

At that time, I already had about two decades of experience doing patent work in plant genetics – mostly with fruits and flowers – so I was very familiar with “cultivar” and “variety” as accepted terms in plant breeding and patent-speak.  But I was newer to Cannabis conversations; I had adopted the vernacular of the industry and used the word “strain” the way most other people did.  So this conversation spurred me to do some thinking and a little research and led me to write a blog post on the topic.  To summarize that post, I explained that “cultivar” was the most correct term to use in reference to plants that result from breeding and selection; “variety” could also refer to naturally occurring groups of plants and was, therefore. a little less precise in reference to plants bred by people; and “strain” had no accepted meaning outside the context of microbes and viruses.

Now that some time has passed, and I have the benefit of countless additional conversations with people from all areas of the Cannabis community and industry, I have revised my prior thinking on this topic.  I see the traditional usage of “strain” in Cannabis vernacular as being generally consistent with the usage of the term in other fields of biology.  In fact, I think it is a more correct term for a selection that has been made from a breeding process.  This approach reflects a commendable acknowledgement of the fact that, in most cases, what people call strains would not be fully qualified to be called cultivars.

For something correctly to be called a cultivar, it must be substantially uniform and stable.  As anyone who has done much with Cannabis genetics is aware, finding a single plant with some desirable combination of traits is great, but that is usually an early stage in a much longer process.  To produce – from seeds – plants with that combination of traits, making the initial selection is usually followed by numerous additional steps (and years) of crosses, selections, and more crosses.  Eventually a group of plants can be produced that consistently and uniformly express the desired traits.  At the end of this process, when the breeder has a stable seed line, it is appropriate to call that line a cultivar.  To apply the term cultivar to any of the earlier stages would be incorrect or misleading, because it would imply a level of stability and uniformity that wouldn’t yet exist.

So what should we call that first selection, or any of the generations that come after it but that don’t qualify to be called a cultivar?  The traditional use of “strain” in this situation is perfect.  Yes, it’s an unusual usage scientifically because the usage is usually reserved for microorganisms.  But why is that the case?  With some important exceptions, new strains of microorganisms are not the result of intentional breeding and selection to the point of uniformity.  They are just identified based on a set of traits and then named.  Frankly, I think the use of “strain” among Cannabis breeders reflects a commendable acknowledgement that what they have, while it may be something interesting, may not be uniform or stable.

Of course, when a new strain is propagated by cloning, it’s very likely that the clones will be uniform.  Will they be stable, generation after generation?  Not always.  That is why it’s best to avoid taking clones of clones of clones (etc.) if mother plants from an earlier generation are still available for cloning.  Even with cloning, while we can usually expect uniformity, there’s no guarantee of stability; in fact, there’s a working assumption against stability, or nobody would worry about taking clones of clones of clones.

If a clonally propagated line is substantially stable, it is appropriate to call it a cultivar.  But, again, there is nothing wrong with calling it a strain, as a kind of admission that nobody really knows how stable it will be over numerous generations of cloning.

And this is why the term “strain” no longer strains me.

Guest Writer: Ian Johnson, Registered Patent Agent, Plant & Planet Law Firm

 

Introduction

Over the past two decades, cannabis has seen increasing public approval, reflected in legalization of medical and recreational marijuana at the state level and federal legalization of industrial hemp. As cannabis and related industries expand, participants are expected to seek competitive advantages, including patent protection. This report examines trends in United States patent filings and issuances related to cannabis since 2000.

While cannabis legalization has been slowly occurring since the 1990s, a significant development was the legalization of recreational marijuana in Colorado and Washington in 2012. Since then, several other states have followed in opening up recreational markets. Therefore, particular attention is given to activity since 2012, as the existence of recreational markets presumably creates greater competition and greater desire to obtain intellectual property protection. This date also conveniently overlaps with the beginning of implementation of the America Invents Act (AIA), which significantly altered the United States patent system. While changes in patent practice post-AIA are beyond the scope of this report, it is useful to examine behavior year over year from 2012 onward to see if legalization has resulting in increased patent activity.

Summary of Findings

Patent activity related to cannabis has increased significantly over the last decade. Filings of cannabis-related patent applications increased 96% between 2012 and 2019, with filings related to recreational and medical cannabis increasing 257% over the same time. The data show that legalization had a demonstrable effect on cannabis patent activity, and that significant resources are being invested in patent protection in the personal use sector of the cannabis industry. These trends are expected to continue, and industry participants should consider this when making decisions regarding business models and intellectual property protections.

Methodology

Research was performed using the LexisNexis Total Patent One database. Results were limited to United States Patent and Trademark Office (USPTO) publications. The following search terms were used:

  • cannab* – use of the wildcard * returns results for cannabis, cannabinoid, and other variants
  • mari?uana – use of the wildcard ? returns results for marijuana and marihuana
  • tetrahydrocannabinol
  • hemp

The listed terms were searched in the title, abstract, or claims of issued patents and printed publications. Searches were limited by time periods as shown in the detailed results. A complete list of all returned documents was created. Because of the structure of the data, a patent could create multiple documents: an issued patent and one or more published applications. For year-over-year results, these duplicates were not removed. This is not considered significant, as publication of an application and issuance generally occur in different years so double counting is minimal. However, duplicates were removed in calculating the number of filings each year to avoid inflation of filing numbers.

Detailed Findings

Overall Cannabis Patent Trends

Cannabis patent activity has increased notably since 2012. Between 2000 and the end of 2011, the USPTO published 3876 documents concerning cannabis inventions. This number consisted of 2865 published applications and 1011 issued patents. Between 2012 and the end of 2019, the USPTO published 5853 documents, consisting of 3980 published applications and 1873 issued patents. This represents 51% more total documents in 2012-2019 compared with 2000-2011. Publications increased year-over-year since 2012, with a 138% increase between 2012 and 2019.  The charts below demonstrate this trend.

Because patent applications are generally not published until the earlier of issuance or 18 months following filing, publication trends are presumably delayed from filing trends. Therefore, it is useful to examine filing trends since 2012. Because of the 18-month delay prior to publication, data for any filings after July 1, 2018 are incomplete as such applications may not have been published. Therefore, both actual values from 2012 through 2018 and projected values for the years 2018 and 2019 are provided below. Using actual filings from 2017, there has been a 75% increase in filing activity since 2012. Using the projected filings for 2019, there has been a 96% increase in filing activity since 2012. The following charts demonstrate the increase in filing of cannabis-related patents since 2012 based on application filing date information.

The AIA transitioned the United State patent system into a first inventor to file system, which is expected to encourage the early filing of provisional applications to secure priority rights. Provisional applications are not published and therefore do not contribute to the publication or filing data above. However, provisional filing activity can be inferred by looking at the claimed priority dates for published applications and issued patents. While the AIA did not fully take effect until March 2013, data are presented since 2012 for ease of comparison with other metrics in this report. Due to incomplete data for 2018 and 2019 as noted above, both actual and projected values are provided. Using actual priority claims for 2017, there has been a 58% increase in provisional filing activity since 2012. Using projected priority claims for 2019, there has been an 80% increase in provisional filing activity since 2012. The following charts demonstrate filing trends based on claimed priority date of the application.

Hemp as a Distinguishing Factor

Hemp has generally enjoyed more acceptance for its industrial uses than marijuana, despite the fact that both constitute cannabis. Inclusion of hemp is necessary to return all results for cannabis related patents. However, to provide a better picture of post-2012 activity in the recreational market, a separate set of searches was performed omitting “hemp” as a search term. It is presumed that doing so will return patents and applications that are more focused on the recreational or medicinal cannabis market. This is based on the fact that many of the results obtained through searching “hemp” include inventions with industrial applications, such as plant fiber composites or textiles, rather than inventions related to personal use of cannabis. For convenience, such patents are referred to as “recreational.” Because this method of discriminating does not perfectly correlate with the subject of any given patent, the results pertaining to the recreational market represent general trends rather than exact activity. Nonetheless, the trends are worth noting for an evolving industry.

“Recreational” Patent Trends

Between 2000 and the end of 2011, the USPTO published 2115 documents associated with recreational cannabis inventions. This number consisted of 1623 published applications and 492 issued patents. Between 2012 and the end of 2019, the USPTO published 3427 documents associated with recreational cannabis inventions, consisting of 2373 published applications and 1054 issued patents. This represents 62% more total documents in 2012-2019 compared with 2000-2011. Total publications increased year-over-year since 2012, with a 253% increase between 2012 and 2019. Published applications saw an increase of 275% over that period, with issued patents seeing a 209% increase. The charts below demonstrate this trend.

Cannabis Patents Trends legalization of medical and recreational marijuana

These findings correspond to the overall increase in cannabis-related patents and demonstrate that the recreational patent sector is growing at an even greater rate than cannabis patents generally. This supports the theory that recreational markets and expansion of legal personal use of cannabis have resulted in an increase in patent activity in the industry.

Again, publication totals are not necessarily the most accurate reflection of patent behavior by cannabis businesses. Therefore, it is useful to examine filing and provisional trends for recreational patents. These results are subject to the same 18-month delay problems noted above, and therefore actual and projected values are provided. Using actual filing data for 2017, there has been a 181% increase in filing activity since 2012. Using projected filing data for 2019, there has been a 257% increase in recreational filing activity since 2012. Using actual priority claims for 2017, there has been a 196% increase in provisional filing activity since 2012. Using projected priority claims for 2019, there has been a 289% increase in recreational provisional filing activity since 2012. The following charts demonstrate recreational filing trends from 2012 to 2019.

Patents that could be classified as recreational made up approximately 53% of all filings between 2000 and 2011. However, following legalization the percent of patents and applications considered recreational has increased to approximately 77% of filings in 2018. The chart below demonstrates the growth of the recreational sector’s share of cannabis patent activity.

Conclusion

In conclusion, the data provide clear evidence that cannabis patent activity has increased over the last decade. Further, patents associated with the recreational and medicinal sectors of the cannabis industry appear to be increasing at an even greater rate.

Further Developments to Watch

The trends demonstrated in the data suggest that cannabis patent activity will continue to increase in 2020 and beyond. This is further expected due to continued legalization efforts. It remains to be seen whether the federal legalization of industrial hemp and implementation of USDA plans will result in the recreational sector’s share of patent activity decreasing, as activity becomes focused on industrial hemp related patents.

An additional area that merits investigation is the issuance rate of cannabis patents. A rudimentary estimate comparing the number of filings to the number of issued patents for 2012-2019 yields an issue rate of approximately 49.6%. Assuming an average time to issuance of 2.5 years, comparing the total filings from 2012-2017 with the total issued patents from 2012-2019 yields an issue rate of approximately 64%. Comparing the total filings from 2012-2017 with the total issued patents from 2014-2019 yields an issue rate of approximately 52%. The issue rates for recreational patents over the same timeframes are similar. However, given the wide variance in time between filing and issuance, the above rates are only speculative. There has been concern that cannabis patents are issued at a higher rate due to the lack of prior art in the field which examiners can cite against the issuance of a patent. The issuance rates noted above do not seem to lend much support to this concern, as the USPTO claims its overall issuance rate is roughly 68%.

Other concerns have been raised about the strength and usefulness of cannabis patents. It is currently unclear how many issued patents are strong enough to survive challenges of invalidity in either post-grant USPTO proceedings or litigation. Currently, only one major cannabis patent is in litigation.[1] As of this writing, the court appears to be treating the case as any other patent infringement suit.[2] However, industry participants will surely watch the case and its outcome may affect the perceived value of cannabis patents and subsequently alter patent activity.

 

 

About the Author

Ian Johnson is a registered patent agent with Plant & Planet Law Firm He works with clients to obtain patents and other protection for their intellectual property and assists clients in licensing, acquisitions, and sales of valuable business assets. He also draws on his experience as an entrepreneur and his broad background across technology, business, and law to support Plant & Planet Law Firm in providing holistic solutions on matters related to business entity formation, corporate governance, and investor relationships. Ian holds a Bachelor of Science in Engineering with a concentration in acoustics from Purdue University. He anticipates receiving his J.D. from the University of Florida Fredric G. Levin College of Law in May 2020. He can be reached at ijohnson@pnplf.com.

 

Plant & Planet Law Firm was founded with a mission to provide legal services to clients whose research, technologies, products, innovations and businesses make the world a better place. The firm leverages its professionals’ variety of legal and technical backgrounds to provide clients solutions in the areas of intellectual property, business law, international law and commerce, and more. The firm is proud of its involvement in the emerging legal cannabis industry, and is also heavily involved in the agriculture, water, clean energy, life sciences, and medicine industries. Plant & Planet is a trusted home for inventors, entrepreneurs, and companies looking to improve the world. All the firm’s activities are tied to its mission statement: “Our clients make the planet better.”

 

[1] United Cannabis Corp. v. Pure Hemp Collective Inc., No. 1:18-CV-01922 (D. Colorado filed July 30, 2018).

[2] United Cannabis Corp. v. Pure Hemp Collective Inc., No. 18-CV-1922-WJM-NYW, 2019 WL 1651846 (D. Colo. Apr. 17, 2019) (Order Denying Defendant’s Early Motion for Partial Summary Judgment). Discovery in the case is ongoing at the time of this report.

 

Cannabis Patents Trends legalization of medical and recreational marijuana

 

 

DISCLAIMER: This report is for informational purposes only and does not constitute legal advice. No attorney-client relationship is created by this report. Neither the author nor Plant & Planet Law Firm will be liable for any harm arising from actions taken in reliance on any information herein.

LET’S DO THIS, AND DO IT RIGHT

Making the Most of Good Intentions and Energy

We all know there are abuses of power and of legal frameworks in the Cannabis industry.  Many good people want to know what they can do about such abuses.  Since I’m a patent attorney, I usually focus on people’s concerns about abuses within the patent system and how they affect the industry and the “Small Cannabis” community.

Patents can be focused, broad, or overbroad/abusive.  I see people discussing Cannabis patents that, with good intentions and abundant energy, misinterpret relatively focused patents as being overbroad.  These situations get earnest people upset and misdirect their energies and attention away from the real problem patents.  Related to this, I get frequent questions about what someone can do to attack an overbroad patent.  I have plenty to say about that, so hang with me.  I think this will be worth your time.

First, Some Definitions

Focused/narrow patent – covers subject matter that was clearly originated by the patent applicant, doesn’t make any real attempt to go beyond that.

Broad but legitimate patent – covers, at its core, something that was legitimately invented by the applicant.  Also covers some logical outgrowths of the core invention but doesn’t cover what is already in the public domain.

Overbroad patent – covers subject matter that was already in the public domain prior to the patent’s filing date.

Some people will want to debate whether all broad patents are abuses, and will argue that anything beyond a focused patent is worthy of attack.  Some of those people are even law professors.  So if you feel this way you’re in good company.  But that’s not today’s topic, so I’m going to direct this discussion to overbroad patents, how to recognize them, and what to do about them.

I also don’t want to get bogged down in, or have this blog dismissed as, an attack on any particular overbroad patent.  This blog may well give you some tools to do that, but I want to be more general and widely applicable.

It’s All About the Claims

The first thing you need to know, to understand a patent or patent application you’re looking at, is that the claims are where the action is.  If you scroll to the end of the part of the document that contains text, you will see one or more numbered, probably long, “sentences” that are usually written very oddly.  Those are the claims.  A patent claim is a verbal definition of the invention and, if you’re looking at an issued patent, the claims are a verbal description of the patent owner’s right to exclude.

Think of a claim as a word-fence around the invention.  If you’re inside the fenced area (i.e., if your product or method meets each and every feature recited in the claim), you infringe the claim.  You are trespassing on the property of the patent owner.  But if there is even one thing the claim recites that your product or method clearly doesn’t have, then you are outside the fence and you don’t infringe the claim.  You are not trespassing; good job!  To read more about patents as fences, click here.

One other thing about patent fences: if a patent fence encloses something that was previously in the public domain, the fence is in the wrong place and needs to come down.  In other words, if a patent claim “reads on” something that already existed before the inventor’s alleged invention, the claimed invention isn’t new and therefore isn’t valid.  Some patent fences, intentionally or accidentally, reach out to cover things that pre-existed the patent.  They are invalid, and the intentional ones are outright abuses of the system.

Knowing What You’re Looking At

So now you know where to find the claims and what they are.  Next let’s figure out whether you are looking at a published application or an issued patent.  And if it’s an issued patent, let’s determine whether it is a plant patent or a utility patent.  That is a very important difference.

Check the numbers on the first page of the document, near the top.  If the number starts with what looks like a four digit year, followed by some more digits, you are looking at a patent application.  If the number is four or five digits and is preceded by “PP” you are looking at a plant patent.  If the number is either 7 or 8 digits, you’re looking at an issued utility patent.  (This is all in reference to US patents and applications.  The numbering system can vary from country-to-country.)

Now that you know what you’re looking at, let’s discuss whether it is worth getting upset about it.

Patent Application – If you see a number like US 2019012345, you’re looking at a published patent application.  Almost all patent applications are published about 18 months after their earliest filing date or priority date.  Most patent applications contain claims that don’t end up getting allowed.

Think of the claims in a patent application as a letter to Santa.  They are a wish list, or the opening round in a negotiation with the patent examiner.  So if you’re looking at a patent application, just realize that the claims you see are not allowed, and don’t necessarily indicate what is really patentable.  They could all be allowed, but chances are fairly good that the final claims in the issued patent will be narrower than the wish list you see in the claims of the published application.

You might see some claims that would be a terrible encroachment on the public domain if they were ever allowed.  You can follow what happens with examination process on “Public PAIR.”  Click here for a blog post that tells you what you need to know to access Public PAIR and become a true patent geek.  And, in certain circumstances, you may even file a protest during the examination process.  This kind of protest requires evidence of unpatentability in the form of printed publications and/or prior patents.  Meanwhile, your best attack on these claims may not be in the form of published material that predates the application.  But if you do have some prior publications that would be on point, you can read about formally protesting pending claims by clicking here.

Plant Patent – If you see a number like US PP12,345, you’re looking at an issued plant patent.  Go to the last page of text and you’ll see there is only one claim, and the claim reads more or less “A new and distinct Cannabis sativa plant named XYZ as illustrated and described herein.”

Here is the most important thing about plant patents: they ONLY cover identical clones of the claimed plant, and you can only infringe a plant patent by asexually propagating (cloning) the patented plant without permission; or by using, selling, or importing parts of the plant (like the flower) without permission.  Therefore a plant patent is a lot like a copyright on a plant—if you aren’t directly copying it, you’re not infringing.  That also means that a plant patent can’t cover things like seeds, which aren’t exactly identical to the claimed cultivar.  Likewise, a plant patent cannot cover using the plant to breed other varieties.

One other important—and frequently misunderstood—thing about plant patents.  They are required by law to include a description of the plant in as much detail as is reasonably possible.  So you may see, in the body of the application, things about the plant’s chemotype or other descriptive information.  This description DOES NOT mean that the applicant is trying to—or ever could—cover all plants with those features.  That description is only there because the law requires it.  So take a deep breath and save your fierceness for certain utility patents, because a plant patent cannot really be overbroad according to our definition.  It’s not possible for a plant patent to cover someone else’s work–something the breeder didn’t invent.  Since a plant patent can only ever cover what the breeder actually originated—one single genotype—there’s nothing to get upset about.  You will do the most good for the most people by focusing on overbroad utility patents.

Utility Patent – you know how to recognize a utility patent and distinguish it from an early wish list (a published application) or a harmlessly narrow plant patent.  Don’t get stuck on the title or the abstract or even the description in the body of the application.  Those all carry information but they DO NOT tell you what the patent actually covers.  Instead go to Claim 1 and read it.  It might be a bit of a slog, but you’ll figure it out.  As you read it, ask yourself whether the claim describes something that you know from your own experience which:

– was sold, published, or otherwise known to the public;

before the earliest filing date or priority date listed on the first page of the document.

If Claim 1 (usually the broadest claim in the patent) really does describe something that existed and was known to the public before it was “invented” by this patent owner, then the claim was erroneously granted and won’t be valid.  For something to be validly patentable, it must be new.  If something was already known before, it was part of the public domain or the public knowledge and isn’t eligible for patent protection.  To read more about patenting and the public domain, click here.  To read more about the almost-always impossibly broad “chemotype patents,” click here.

You Found a “Bad” Patent, Now What?

So what can you do about an issued patent that you believe covers something that wasn’t new at the time of filing?  You have some options.  You could file an “Inter Partes Review” or an “Ex Parte Reexamination” at the USPTO.  These are limited in their potential because they will both require evidence in the form of prior patents or printed publications.  This is especially challenging in the Cannabis industry, in which most of the prior commercial activity was never published—it was intentionally hidden from the outside world even though well-known inside the community.  So if your evidence that the claimed invention was in the public domain exists in some other form—like witness testimony—then you have some other options that will work better.

Your least expensive and most proactive option is to publicize what you know about the claim’s lack of novelty.  Get on social media and publish blogs and articles to point out your evidence that a particular claim is overbroad because it covers things that aren’t new or original to the patent owner.  Be specific about what you know.  And if you’re worried about the noise you’re making constituting some kind of incriminating admission of prior illegal activity, check with a lawyer.  Chances are good that any such activity has a statute of limitations.  Remember, this blog is NOT legal advice–you really do need a live lawyer to learn and analyze your exact facts.

Making Noise for the Public Good

What is the benefit of this kind of publicity?  Well, it may make the patent owner think twice about ever suing anyone for infringing the overbroad claim.  This is because patent litigation is expensive and if you sue someone for patent infringement, one of their defenses can be that the patent is invalid and never should have been granted.  A defendant will have a full opportunity to bring forth a variety of evidence to demonstrate that the claimed invention wasn’t new.  And if the court agrees with this, it will rule that the claim is invalid.  A final judgement that a claim is invalid means it can never be asserted against anyone, ever again.

So if you make a lot of noise about an overbroad patent and why it is invalid, the patent owner may well decide that it is too risky to sue someone who could turn around and invalidate the patent claims.  If your evidence is clear and credible, it would be pretty foolish for the patent owner to sue anyway.  And one thing about big corporations is that they often have shareholders and board members who will be very upset if money is wasted in litigation where an invalid patent is the only outcome.  So the more noise you make (if it is credible), the more you raise the awareness among investors and board members of how risky it would be to ever sue someone.

Defending Your Community

This is related to another aspect of preventive noise-making.  It shows a cohesiveness in the community—that one person’s evidence can be everyone’s defense.  If you are standing up to a bad patent, others will be more likely to stand with you.  This should especially be the case if someone actually were to be sued for infringing an overbroad patent.  If everyone in the Small Cannabis community were willing to share their evidence of patent invalidity to help the defense of one member of the community, you can be sure that Big Cannabis or Big Ag would become aware of this and would be more hesitant to assert overbroad patents.  To read more about standing up to Big Ag, as a united Small Cannabis community, click here.

The Small Cannabis community is rightfully concerned about the threat of overbroad patents.  But Small Cannabis is not paralyzed by fear—it is instead energized by a righteous kind of anger and willingness to stand its ground.  The more effective the community is in pointing out overbroad patents with real, credible evidence, the less likely Big Cannabis will be to continue to try to enforce these patents or even pursue them in the first place.  At some point, the investors and board members of Big Cannabis will see overbroad patents for what they are: a colossal waste of money and political capital.

So go make some noise, after doing some homework to make sure you’re targeting the real abuses.  Your brothers and sisters in Small Cannabis will stand with you and thank you for your efforts.

*Photo — Propagating Purpose Presents: The Grassroots Roundtable Discussion; August 24, 2019; Ukiah, CA; “The Giant We All Face”

OPEN SOURCE WITHOUT ANY RECOURSE AGAINST VIOLATORS IS JUST AN HONOR SYSTEM

Don’t Kill the Messenger – But Please Read His Blog!

We have all heard of open source and are aware of how well it seems to work in the software industry.  And many of us have heard discussions of how desirable it would be to have a workable open-source system in Cannabis breeding.  I hate being the bearer of bad news, but a workable open-source system in Cannabis breeding (or any plant breeding), at least one that is in any meaningful way analogous to open-source software, isn’t possible under current laws in most places.

Before you decide to kill this messenger, I do have a proposal for a solution.  It’s not a particularly modest proposal but I think it’s an important one and should be pursued.  To state it differently, I am IN FAVOR of having open source as an option for Cannabis breeders, but we can’t get there from here unless some major changes in the intellectual property system happen first.  So let’s explore those changes, why they are necessary, and how to make them happen.

Open Source vs Public Domain – Not the Same Thing

Open-source systems were created in the software community in order to facilitate sharing, research, understanding and further development of software with fewer restrictions than those governing typical commercial software. However, it is important to understand the difference between an open-source system and an absolutely free-use or public-domain system. In open source the software source code is shared widely but with conditions. In contrast, in a free use or public domain approach the source code of the software would be dedicated to the public – expressly put into the public domain – such that the originator would retain no rights of any sort to control who used the source code, or for what purpose, or under what conditions. Even though open source is associated with broad access and sharing, it still carries conditions. Typically the condition is that software incorporating open source code must itself be made available under the same terms for others to use, study, and build upon.

The motivation behind an open source approach to Cannabis breeding (or any plant breeding) is that the rich genetic diversity available from different sources, different plant breeders, different collections of exotic or rare genetics, ideally would be shared with others. This would be so that they could use their access to this great source of genetic diversity in developing new cultivars as well as simply to preserve biodiversity and improve the overall gene pool of cannabis cultivars developed by plant breeders. So why not just create a free use/public domain system? Because, at least among some participants, there is a reluctance to hand over their special, rare genetic material in the form of seeds or clones for others to use if the recipient would not be willing to share with the community on similar terms. Typically, participants in an open source system are embracing a non-commercial or less commercial approach to breeding and do not want that “community value” to be siphoned off to parties with different values and different goals.  They want to restrict access to this precious genetic material only to those who are willing to respect the community and play by the same rules. Obviously, if someone is committed to a fully open sharing of genetic material, they are always free to do that by placing their material into the public domain and letting it scatter as it will. But I don’t think that’s usually what people mean when they talk about open source cannabis genetics.

Software is Different – It Has Automatic Copyright Protection

But first some background so we can fully appreciate the problem:  when someone writes code for software, that code is automatically protected by copyright the moment it is written.  There is nothing the writer needs to do for that copyright protection to exist other than to write the code.  It’s the same for this blog post.  As soon as I write it, it has copyright protection.  Done.  Easy.  Automatic.

Of course, if I want to have full leverage to enforce my rights as a copyright owner or be in the best position to get revenue from giving someone a license under my rights as a copyright owner, there are some additional steps I need to take.  So there still exists a formal, government-based system to “perfecting” or documenting copyrights, but the law of copyrights in most of the world is that they exist upon creation of any written work having a modicum of creativity and skill.

This makes an open-source system for software easy to create and enforce.  Simplifying (because this IS a blog and because open-source software systems are not my area of expertise), an open-source system is an agreement among participants who are willing to abide by the agreement.  In simplest terms, it’s a group deal that says “anyone who promises to only use this code in an approved way, and not to use it in a disapproved way, is free to use the code in developing their own software.”  Users who abide by those conditions are in compliance and all is well.  Those who go outside those conditions and use the code in ways that are not licensed under the open-source agreement are committing copyright infringement and are at risk of being sued, shut down, and liable for money damages.

Legal Recourse is the Essential Stick to Accompany the Open-Source Carrot

Why is this so easy and why does it work so well?  Precisely because the code is already (automatically) covered by copyright.  So going outside the agreement is plain and simple copyright infringement.  The point is that the copyright protection provides recourse against those who don’t play by the rules.

The contrast with plant genetics is clear: there is no automatic protection for plant breeders that would cover their rights in a clone or a seed they originated.  The only way to get that kind of protection is to apply for IP rights in the form of a plant patent, a utility patent, a USDA PVP certificate, or analogous rights Plant Breeder’s Rights (PBR) in other countries, almost all of which arise from the International Union for the Protection of New Varieties of Plants (UPOV).*

*In case you are curious about the acronym UPOV, it’s based on the name of the convention in French.  For more on the UPOV system, click here or here.

Alternatives to an Honor System

In the absence of any enforceable rights against people who don’t play by the rules, an open-source system for Cannabis genetics is nothing more than an honor system.  There is a lot to like about honor systems but we all see the problem—the dishonorable who refuse to play by the rules.  In open-source software they are called copyright infringers and can be sued.  In open-source Cannabis genetics, they are called sunzabitches and can only be disliked.  Do you see the contrast between the two systems, and the inherent problem?

I can only think of three solutions to this.  Unfortunately, they are all hard.

  1. Obtain IP protection for everything that is going to be part of the open-source system.
  2. Very strictly control access to the Cannabis genetics only to those who agree to the rules of the system.
  3. Change the law of plant breeding so that any unique genetic selection has some level of automatic protection upon creation.

Let’s analyze the pros and cons of each option:

  1. Obtain IP protection for everything that is going to be part of the open-source system.

One major problem with this is that is seems to run counter to the reason many people want open-source in the first place.  They want to keep things simple and many of them are not big fans of IP protection, at least as they think of it.  Typically they don’t have any major objections to IP in the form of copyrights, but they see plant IP as something different.

Also, there’s no avoiding the fact it’s quite a process to jump through all the hoops of obtaining IP protection for plant genetics.  That’s true even if you are working with someone (like me) who does this all the time and has for decades.  It’s still necessary to prepare an application, file it, pay a filing fee, wait a while, maybe do some more work to get it allowed, maybe also make a deposit of seeds or tissue, and pay an issue fee.**  So it’s complicated—vastly more complicated than it is with software.

**This is a simplified summary of the various hoops.  They don’t all apply in every system.  But at least three from the list are unavoidable in any system.

Why would it be necessary to get IP protection for everything in the system?  Because you need some kind of legal recourse against those who refuse to play by the rules.  In software it’s straight-up copyright infringement.  In this scenario it would be straight-up infringement of a patent or a PVP or PBR certificate.  Otherwise, again, you’re just using an honor system, when the problem is the behavior of the dishonorable.

  1. Very strictly control access to the Cannabis genetics only to those who agree to the rules of the system.

In this approach, the only people who ever could get their hands on a clone or a seed in an open-source system would be people who had already agreed, in a legally-binding way, to abide by those rules.  To be very clear, that legally-binding agreement would be some form of a group contract.  So anyone who made such a legally-binding commitment and then didn’t end up abiding by the rules would be in breach of contract.  There would be legal recourse against them.

The problem with this approach is security.  You’re really just creating a different kind of honor system, one that would be nearly impossible to trace, govern, or enforce if it grew beyond two or three members.  In this case the honor system is what people do with the genetic material they get access to.  What if they are careless with it and it gets out to a third party who never agreed to abide by the group contract?  You can’t be in breach of a contract to which you’re not a party.  So there may be some recourse against the careless member of the group, but there’s zero recourse against anyone who didn’t sign that contract.

This means that the system is only as good as the carefulness and security of the system.  Imagine how hard that would be to control.  It seems pretty much impossible.  And this is exactly why people end up seeking IP protection.  It gives you recourse against people with whom you never made an agreement – even against people you never heard of until you learned they were infringing your IP rights.  That’s usually the exact kind of recourse you need and can’t otherwise get.

  1. Change the law of plant breeding so that any unique genetic selection has some level of automatic protection upon creation.

OK, so we don’t like the problems with the first two options.  Let’s just change the law worldwide!

Notwithstanding how hard it would be to change the law in the US and across the world, this approach would make everything after that directly analogous to the open-source software system.  So there’s something to like about this.  The hardest work is done up-front and once per country, instead of once per plant variety (under approach #1) or instead of constantly (constant perfect security under approach #2).

My Dad is Such a Pain, LOL

I hear the murmurs—every single seed is, technically, a unique genetic combination.  It makes no sense to protect every single seed ever created.  Here’s my answer: you’re overthinking it.  Just because there is automatic protection for every single seed, that doesn’t mean you’re going to do anything with or about that protection for all of them.  It’s just a starting point that enables you to do what you want with the ones you care about.

To illustrate, I would guess that almost every text message my teenagers send has copyright protection.  OK, not texts that lack any originality, so we can exclude “lol” “wyd?” or “my dad is such a pain” (I’m guessing that’s not ORIGINAL to my kids).  But everything anyone writes that has any originality to it is technically protected by copyright.  Does anyone choose to do anything with or about all those copyrights? Of course not.  That’s not the point.  The point is that the valuable ones (like this blog!) have automatic protection without jumping through hoops, paying fees, and waiting for the protection to be granted.  So anything WORTH putting into an open-source system brings with it the recourse against those who won’t play by the rules of the system.  And recourse is essential to a meaningful, workable open-source system.

International Conventions Work

So all we need to do is change the law worldwide.  Don’t be discouraged—it happened with copyrights.  For a long time there was no copyright protection without registration.  That eventually became a problem—an international wrong that needed to be righted—and something called the Berne Convention was established.  177 of the world’s 195 countries are currently members.  The US finally joined the Berne Convention in 1988, only 102 years after its original establishment in 1886.  But better late than never, right?

How does an international convention get established?  By identifying a problem, promoting a conversation, and taking action.  This can happen with government action or with enough attention from non-governmental organizations (NGOs) that are sufficiently committed to change.  So consider this one of the first steps in a journey of a thousand miles.  But, with enough people understanding the problem and motivated to find a solution, that journey need not be a slow one.

Meaningful Next Steps

  1. If you can think of an alternative to the three hard solutions I have discussed here, please bring it to my attention in the comments or email me at DHunt@PlantAndPlanet.com. I don’t pretend to have all the answers.  I’m just a lawyer with some experience who writes a blog.  So please suggest some alternatives if you can think of some.  (Respectful dialogue is always preferable but if this blog made you upset and that motivates you, bring your passion and I’ll do my best to take the arrows.)
  2. If you think a change to the system of plant IP is worth some of your effort and energy, let’s translate this into more than just a blog. Make a comment or send an email indicating your interest and we will start with a group call and identify some genuine next steps.
  3. If you feel strongly enough about this, you can certainly forward this post to others and ask them to join the movement. I’m pretty sure the Berne Convention in 1886 started with a blog post and some texts and emails—maybe an Instagram rant.  If it worked for them, it can work for us.
  4. Maybe you’re aware of another group that is already on this. Please make me/us aware and we can join forces.

Let’s start something.

ON THESE YOU SHOULDN’T COMPROMISE – BUT LEAVE ROOM TO BE FLEXIBLE ABOUT OTHER THINGS

Behaviors of a Good Partner, Whether It’s a Company, Organization, or Person

This blog post isn’t only for the Cannabis industry.  I think it applies universally.  And I’m not here to rehash Phylos, but it’s impossible to address this week’s topic without starting by acknowledging the “Phylos Effect” on the Cannabis industry.  The company’s admitted mistakes (and perhaps others that haven’t been admitted yet) started a dialogue within the Cannabis community centering on some core issues and topics.  We have hopefully learned some lessons for which we can be grateful.  I would boil the experience down to lessons learned about three principles that are inter-related and of vital importance.  They are (1) Transparency (2) Accountability and (3) Trustworthiness.  Since I am NOT rehashing Phylos, I will discuss these three principles in a forward-looking way.  People who want to look backward certainly can, and their activism undoubtedly energizes these lessons for us all.  My approach is no criticism of them.  I’m just leaving them to that approach while I take this one.

I’ll frame this discussion in terms of companies because they seem, as a group, to have the hardest time with these things.  Part of that might be inherent in corporate formation and function—it seems that the truly special companies take active measures to overcome the pressures, presumptions, and dynamics that disfavor Transparency and Accountability and Trustworthiness.  But this discussion applies equally to organizations and to individual people.  So as you read this, mentally substitute “person” or “organization” where I write “company.”  Ideally all of the parties and entities we deal with would embrace these values and behaviors.  That’s what we should demand.

Transparency – literally this means that you can see through something—that there is nothing to hide and nowhere to hide it.  Organizations and people who act with Transparency say what they mean and mean what they say.  They don’t have a hidden agenda and they don’t have to lie or intentionally mislead about their goals or their business plans.  What you see is what you get.

Accountability – this means that you take responsibility for your actions, your values, and your decisions and even (especially) for your mistakes.  Organizations and people who act with Accountability may not be mistake-free, but they will not try to dodge the consequences of their actions.  If there are some mistakes made or unintended consequences, they address them head-on and make all reasonable efforts to clean up their own messes.  And they welcome the opportunity to do so.

Trustworthiness – the meaning of this is clear: a person or a company is deserving of your trust.  And it’s hard to imagine a situation in which a person or a company would display real Transparency and behave with Accountability and NOT be worthy of Trust.  Does that mean you will always agree with the company’s choices or actions?  Probably not.  But you can at least trust the company to be real about what it is doing and why.

There is Room for Diversity of Priorities and Values

Let’s distinguish the behaviors of Transparency, Accountability, and Trustworthiness from some of the other things we might wish to find in a company – its values.  It’s not realistic to expect every company, organization, and person to have all of the same values that any one of us might have.  Diversity of goals, values, priorities, etc., can be good.  People who tolerate no deviations from their own values are typically dogmatic, inflexible, unreasonable, and no fun!

There is room to trust a company and still not always agree with it.  There needs to be room for that, in any kind of workable industry.  That can be hard for some in the Cannabis industry because it’s not just an industry.  In many ways it’s also a community, especially among the people who have been in it since before the regulated commercial industry emerged.

Things Have Changed

My sense from conversations I’ve had and observations I’ve made is that in the “old days” there may have been an even greater need for some shared values and priorities, as a matter of survival.  Maybe it was easier to draw lines and know who was on which side.

(I wasn’t there so I’m only going on what people have told me.  And I don’t in any way mean to be speaking for them or claiming the experience and credibility they uniquely have on this topic.  I’m only doing my best to synthesize my own experiences and observations and to do something useful with it.)

But things have shifted.  Business pressures can change people from being apparently Trustworthy to behaving differently and being less reliable.  I’ve heard numerous stories about that from clients who misplaced their trust in people they had known.  They didn’t think legal protections like contracts and patents would be necessary and only learned differently when it was too late.

And, strangely, some groups we may have automatically distrusted have now become essential partners if we want a place in a legal industry.  As an extreme example, even if you’re a survivor of intense persecution by the government, you can’t avoid working with the government to get the necessary licenses, pay taxes, and protect your legal rights.  It is an interaction that isn’t perfect and is almost never fun, but it’s a necessary one, nonetheless.

Value Fallacies?  We All Have Them—Some We Hold Dearly

Here are some examples of things that seem to be mistakenly valued in at least some circles.  Some people embrace these values and equate them with measures of Trustworthiness.  But I would argue that these are “value fallacies.”  They will distract us from a more useful focus on Transparency, Accountability, and Trustworthiness by getting us riled up about the wrong things.  You may disagree, even vehemently.  But give these some open-minded thought:

  1. Being anti-corporate – Admit it. Many of us have used the term “corporate” as synonymous with “heartless,” “sterile,” “evil,” and so on.  But in the US, it’s virtually impossible to achieve very much commercially without incorporating in some way.  Refusal to do so will eventually lead to major negative tax consequences and potentially paralyzing liability risks.  And incorporating isn’t a dodge of necessary taxes and all liability.  It’s a way to work within the system that is there, to permit a business to function over the long haul.  People who refuse to incorporate on some kind of moral grounds are playing a competitive game with one hand voluntarily tied behind their back.  It’s simply not realistic or sustainable in most cases.  We can and should distinguish between the good and the bad not based on whether they have incorporated, but based on their behaviors of Transparency, Accountability, and Trustworthiness.
  2. Being anti-success – I have heard numerous conversations and seen countless posts that seem to reflect a near knee-jerk reaction to distrusting any company that is experiencing success or even making an all-out effort to succeed. I believe this comes from experience with companies that chose success over the behaviors of Transparency, Accountability, and Trustworthiness.  It may also arise partly from some frustrations about who appears to be succeeding and who doesn’t.  It often seems that the playing field isn’t remotely level as to some in the community. That is something we should separately address so that all can have an equal shot at success. But I would argue that there is room for truly Trustworthy companies to succeed and, when they do, that should be celebrated rather than criticized or resented.
  3. Being anti-profit – We have been conditioned to treat the concepts of “profit” and “greed” as though they were the same thing. This implies that it’s possible to sustain a business without profit or that it’s impossible to make a sustainable profit unless a business is greedy.  But a business that simply isn’t profitable probably won’t be around long to provide jobs, products, or services.  It won’t be sustainable.  I don’t actually think we mean to criticize the profitability.  We instead may be reflecting our experience and assumptions that the profit was achieved through some untrustworthy behaviors.  Let’s re-examine that and demand Transparency, Accountability, and Trustworthiness without always distrusting profitable enterprises.
  4. Being anti-growth – Some companies get big by means of all sorts of abuses, but some companies get big just by being very good at what they do. It is a value fallacy to dismiss all big companies as being untrustworthy just because of their size.  It may be very appropriate to be skeptical and to demand an even higher level of Transparency and Accountability of larger companies, because it is easy for even the good ones to become distracted or impersonal.  But if all large companies are seen as the enemy, we ourselves are distracted from being prepared fully to take on and stand up to the genuinely bad companies.
  5. Being anti-patent – Of course I was going to get to this—I’m a patent attorney. Many believe that patents are inherently wrong.  But most of these same people use locks of some sort to protect their own property.  They pay for things produced by the labor of others instead of expecting that the labor should have just been donated to the public good.  They pay for creative content such as movies and books and music and usually understand that the artist who originated those things deserves to be paid for their work and talent.  But then for some reason they still believe there is something inherently bad about all patents, when in many cases patenting is the only way for a plant breeder or an innovator to get paid for her life’s work.  Being completely anti-patent means there are certain professions (plant breeder, innovator) that should just dedicate their work to the public domain.  That doesn’t mean that all patents are good or properly granted or appropriate.  Some patents represent invalid over-reaches and are to “good patents” like greed is to profit.  You can hate the abuses without hating the underlying system that sometimes is abused.  If you still don’t see how someone can embrace IP protection, such as patents, and still be an ethical and positive member of an industry and a community, please read this.

Demands and Goals

So is there a take-home message?  Is there a call to action?  Hell yes!

  1. DEMAND TRANSPARENCY – When you are dealing with a business (or an organization or a person), don’t start from a position of trust or distrust. Start from a position of demanding Transparency.  Ask questions.  Investigate.  See what the answers are like.  Are they evasive?  Do they make sense?  Are they consistent?  This is all about Transparency.  If a business lacks Transparency, that is when it’s time to start distrusting the business.  Don’t make it about whether the business is making a profit or trying to.  Don’t even necessarily make it about how big the business is.  Make it about Transparency first.

Be realistic, though, about the fact that many companies have to keep some secrets in order to function.  But there is a difference between keeping company secrets and being deceptive or misleading or outright untruthful.  People need and deserve a certain amount of privacy.  Even companies may need that.  But privacy can’t be a shield for dishonesty.

My goal for all companies is that they would embrace Transparency and welcome investigations and hard questions about how Transparent they really are.  They would be who they say they are and do what they say they are going to do.  We should not accept less from the companies we work with.

  1. DEMAND ACCOUNTABILITY – Observe and learn what you can about the company’s Accountability. Has the company been clear about its rules and values for itself and is it willing to be Accountable to those rules and values?  Does it show real Accountability when a mistake has been made?  Does it show a genuine commitment to fix its mistakes and clean up its messes?

Don’t presuppose that all good companies would have the same values or priorities or rules for themselves.  Allow for each company to define its purpose and mission and values.  But demand to know what they are and how the company will be Accountable for its actions.

My goal for all companies is that they would establish a Company Constitution to articulate the company’s values and priorities, for all to see.  This would show both Transparency and Accountability.  But a further goal is that Company Constitution would also set rules by which the company commits to abide.  Such a company would invite its customers and partners to hold it Accountable in its behavior according to its stated values and rules.  A truly Accountable company would create a Constitution strong enough that it could not be swept away with a change in ownership or control.  Investors would invest knowing what they are getting and would, in so doing, embrace that Accountability.  They would literally “buy in” to the company’s Accountability as part of their investment.

  1. RECOGNIZE AND REWARD TRUSTWORTHINESS – If you demand Transparency and Accountability you will have a Trustworthy company as your partner. If it sounds simple, it’s because it IS simple.

Don’t trust a company that does not consistently show Transparency and Accountability.

My goal for all companies and their customers and partners is that it would become commercially untenable for companies to be unwilling to consistently abide by the principles of Transparency, Accountability, and Trustworthiness.

And finally…

My goal for all of us is that we would not only demand these things of the companies and organizations and people around us, but that we would do our best, day in and day out, to abide by the same principles.  That we would also demand Transparency, Accountability, and Trustworthiness of ourselves in our dealings with others.

We as an industry and as a community will never get what we don’t consistently demand.  If there is a single most important lesson to be learned from recent events in this industry, this is it.  And it’s a lesson for any industry—maybe any relationship.